FDA Approvals

Date Posted
Article Title
12/11/2014
Screening Test Approved for Viruses That Cause Blood Cancer

Screen looks for viruses tied to a number of blood cancers or abnormalities

12/10/2014
Gardasil Approved for Additional Types of HPV

Virus can lead to cervical cancer

12/4/2014
Jakafi Approved for Chronic Bone Marrow Disease

First drug sanctioned in U.S. for polycythemia vera

12/3/2014
Blincyto Approved for Rare Leukemia

Drug sanctioned for rapidly-growing form of bone marrow cancer

11/20/2014
Abuse-Resistant Prescription Painkiller Approved

Hysingla ER is only for chronic pain, and is formulated to resist crushing, dissolving

10/29/2014
10/24/2014
New Treatment Approved for Rare Form of Hemophilia

The bleeding disorder affects both males and females

10/16/2014
Esbriet, Ofev Approved to Treat Deadly Lung Disease

Drugs help slow decline of idiopathic pulmonary fibrosis

10/14/2014
Urinary Prosthetic Device for Women Approved

Helps those who can't contract bladder muscles

10/13/2014
Drug-Coated Balloon Catheter Approved

Designed to clear clogged arteries in thigh and knee

10/10/2014
Akynzeo Approved for Side Effects of Chemotherapy

Drug helps ease nausea, vomiting

9/23/2014
Blood Test for Yeast Infections Approved

Rare infections primarily affect people with weakened immune systems

9/19/2014
Trulicity Approved for Type 2 Diabetes

New drug helps regulate blood sugar

9/16/2014
Movantik Approved for Constipation From Opioids

Painkillers frequently cause irregularity

9/11/2014
Novel Weight-Loss Drug Is Approved

For obese people or overweight people with weight-related health condition

9/5/2014
NephroCheck Test Approved to Predict Kidney Injury Risk

Screens for decline of kidney function within 12 hours

9/4/2014
Keytruda Approved for Advanced Melanoma

Nearly 10,000 in U.S. expected to die this year from deadly skin cancer

8/21/2014
New Test Helps Diagnose Type 1 Diabetes

But negative result doesn't rule out disease, FDA warns

8/20/2014
Cerdelga Approved for Gaucher Disease

People with rare disorder lack key enzyme

8/15/2014
Avastin Approved for Late-Stage Cervical Cancer

More than 4,000 women projected to die this year from the disease